SOURCE: Beneo Institute

BENEO Institute

April 14, 2016 14:00 ET

BENEO Secures 2nd Authorized 13.5 Health Claim in 2016 for Its Chicory Root Fibers

Inulin and Oligofructose Contribute to a Reduction in Blood Glucose Rise

MORRIS PLAINS, NJ--(Marketwired - Apr 14, 2016) - Functional ingredients manufacturer BENEO announced today that the Standing Committee on Plant, Animals, Food and Feed has agreed with the EU Commission in its meeting on April 12, 2016, to authorize a second 13.5 health claim for the company's chicory root fibers.

The announcement comes just three months after the company received its first 13.5 health claim for its chicory inulin at the beginning of this year. The recent health claim confirms that inulin and oligofructose contribute to a better blood glucose management as they support a lower rise in blood glucose response. The wording for the claim may read "Consumption of food/drinks containing inulin/oligofructose instead of sugars induces a lower blood glucose rise after their consumption compared to sugar-containing foods/drinks" when BENEO`s chicory root fibers are used. The EU Commission will now continue with the publication of the health claim in the EU Official Journal, which is expected within 4 to 6 weeks, at which time the claim can be used in the market. 

In addition to the authorized 13.5 health claim, general health-related well-being claims under article 10.3 are also possible. Among others, these may include "lower and more balanced blood glucose rise." A 30% sugar reduction needs to be obtained by replacement with non-digestible carbohydrates such as BENEO's inulin and oligofructose according to the conditions of use. The authorization is based on several scientific studies all of which confirm that oligofructose and inulin have a significant part to play in the area of glycemic control.

About 422 million people worldwide have diabetes, a number that is likely to more than double in the next 20 years. More than 90% of these people suffer from diabetes type II1 so preventative measures, such as healthy eating, are a key area of concern. Leading scientists agree that a low glycemic diet reduces the risk of type II diabetes and helps to control blood glucose levels, a factor that's particularly important for people who already suffer from diabetes. Consumer awareness around the issue is growing and as a result, many more consumers are now seeking low glycemic products. The new health claim supports them in more easily identifying these products and also helps manufacturers in developing a greater variety of low glycemic choices in response to this consumer need. 

BENEO's inulin and oligofructose, derived from chicory root, contribute to a lower glycemic response of food and drink products because they are not digested in the human digestive system and thus no glucose is released into the blood stream. Replacing high glycemic ingredients (e.g. sucrose, glucose, maltodextrin) using BENEO's dietary fibers that do not cause a glycemic response consequently lowers the blood glucose response of the final product and adds a valuable fiber source at the same time.

"Blood glucose management is a key element in the promotion of long-term health from early on," said Anke Sentko, BENEO's VP of Regulatory Affairs and Nutrition Communication. "Consumers are increasingly aware that carbohydrate-based, low glycemic products contribute to healthy nutrition. The new health claim for BENEO's dietary fibers inulin and oligofructose confirms once again the strong scientific evidence behind our ingredients. But more importantly, it offers manufacturers the opportunity to help consumers make better choices in a daily diet that supports a low glycemic nutrition," she added.

The BENEO-Institute is an organisation, which brings together BENEO's expertise from Nutrition Science, Nutrition Communication and Regulatory Affairs teams. It acts as an advisory body for customers and partners reaching from ingredient approval, physiological effects and nutritional composition to communication and labelling. The key nutritional topics that form the basis of the BENEO-Institute's work include weight management, digestive health, bone health, physical and mental performance, the effects of a low glycemic diet in the context of healthy eating and disease prevention, as well as dental health.

The BENEO-Institute facilitates access to the latest scientific research and knowledge throughout all nutritional and regulatory topics related to BENEO ingredients. It provides BENEO customers and partners with substantiated guidance for some of the most critical questions in the food industry. BENEO is a division of the Südzucker Group, employs almost 900 people and has production units in Belgium, Chile, Germany and Italy.


Contact Information

  • For further press information, please contact:
    Valerie Harding
    Ripple Effect Communications
    Tel: +1 617 536 8887
    Email: Email Contact

    For further information or interview requests, please contact:
    Claudia Meissner
    Head of Corporate Communication BENEO
    Tel +49 621 421148
    Email: Email Contact